Research Article
Cryoablation of Primary Breast Cancer in Patients with Metastatic Disease: Considerations Arising from a Single-Centre Data Analysis
Table 2
Data relative to the cryoablation procedures in the study population.
| | | Number (%) |
| | Total number of treatments performed | 48 (100) | | Upfront cryoablation treatment | 35 (72.9) | | Redo cryoablation for incomplete necrosis | 5 (10.4) | | Redo cryoablation for local recurrence | 7 (14.6) | | Cryoablation for new contralateral breast cancer | 1 (2.1) | | Types of probe used for cryoablations | | | IceRod | 48 (50.0) | | IceRod Plus | 28 (29.2) | | IceSphere | 20 (20.8) | | Number of cryoprobes used per treatment | | | 1 cryoprobe | 9 (18.7) | | 2 cryoprobes | 30 (62.6) | | 3 cryoprobes | 9 (18.7) | | Synchronous cryoablation of metastases | | | Axillary lymph node | 2 (4.2) | | Sternal bone | 1 (2.1) | | Two-month follow-up MRI/CT scan | | | Complete tumor necrosis | 30 (85.7) | | Incomplete tumor necrosis | 5 (14.2) | | Six-month follow-up MRI/CT scan | | | Complete tumor necrosis | 35 (100) | | Incomplete tumor necrosis | 0 (0) | | Complications | | | Major complications | 0 (0) | | Minor side effects | 30 (82%) |
|
|
